Antimicrobial Dosing Individualization Based on Pharmacokinetic/Pharmacodynamic Evaluation, Considering Factors of “Patient”, “Site of infection” and “Microorganism”
Open Access
- 1 October 2024
- journal article
- review article
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 144 (10) , 937-943
Abstract
The pharmacokinetic (PK)/pharmacodynamic (PD) approach has been widely used in clinical practice to optimize antimicrobial treatment. To promote the appropriate use of antimicrobial agents, it is important to consider certain factors, such as patient (e.g., age, physique, medical history, comorbidities, and organ dysfunction), site of infection (the target site where many causative bacteria are present), and microorganism (causative bacteria and susceptibility), and the dosing regimen should be selected based on the PK/PD approach. However, for renally excreted antibiotics, dosing regimens based on only renal function, such as creatinine clearance, are mainly used. Therefore, other factors such as patient pathological factors, antibiotic penetration of target sites, susceptibility of the causative bacteria to antibiotic, and clinical evaluation (efficacy and toxicity) should be considered simultaneously. These studies aimed to tailor the dosing of antimicrobial agents to individual patients by considering these factors. Multifaceted PK/PD evaluation may improve antimicrobial efficacy and safety, thereby contributing to the successful treatment of infectious diseases. Furthermore, improved treatment success rates may help manage the prevalence of antimicrobial-resistant bacteria, which is expected to become a significant problem in the future.Keywords
This publication has 18 references indexed in Scilit:
- Pharmacodynamic Evaluation of Ampicillin-sulbactam in Pediatric Patients Using Plasma and Urine DataThe Pediatric Infectious Disease Journal, 2022
- Prostatic Pharmacokinetic/Pharmacodynamic Evaluation of Ampicillin‐Sulbactam for Bacterial Prostatitis and Preoperative ProphylaxisThe Journal of Clinical Pharmacology, 2020
- Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patientsInternational Journal of Antimicrobial Agents, 2014
- High plasma linezolid concentration and impaired renal function affect development of linezolid-induced thrombocytopeniaJournal of Antimicrobial Chemotherapy, 2013
- Thrombocytopenia and anemia caused by a persistent high linezolid concentration in patients with renal dysfunctionJournal of Infection and Chemotherapy, 2011
- Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunctionInternational Journal of Antimicrobial Agents, 2010
- Database for Physiologically Based Pharmacokinetic (PBPK) Modeling: Physiological Data for Healthy and Health-Impaired ElderlyJournal of Toxicology and Environmental Health, Part B, 2008
- Prevention of Resistance: A Goal for Dose Selection for Antimicrobial AgentsClinical Infectious Diseases, 2003
- Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parametersClinical Microbiology and Infection, 2001
- Pharmacokinetic Study of Sulbactam and Ampicillin Administered Concomitantly by Intraarterial or Intravenous Infusion in the NewbornClinical Infectious Diseases, 1986